Along with the trend analysis, quantitative data includes five-year
trends (2006-2010) on number of establishments, industry and number of
employees. This data is developed through Trendologys economic model
using regression analysis based on historical industry trend data.
Forecasts are available for 2010. Quantitative data for current year
2009 is provided for the U.S., 50 U.S. states, and 900 metro areas. Read the rest of this entry »

Although the drug development industry still focuses primarily on small
molecules, in recent years protein and peptide therapeutics comprise a
significant percent of the product line and pipeline for most major
pharmaceutical companies. Peptide and protein therapeutics, especially
antibody drugs, are attractive due to their high specificity and potency
and low incidence of toxicity. Developments in manufacturing, Read the rest of this entry »

The rate of drug failure — be it at the approval stage or post launch —
may have increased only slightly, but that rate has to be seen in the
context of a long term decline in new products being brought to the
market. Over the last 10 years, the regulatory demand and commercial
imperatives facing the industry have been growing. Safety has become a
key issue, allied to the need not only to prove efficacy, but Read the rest of this entry »

The study highlights the recent regulatory reforms initiated by the
German government and the market opportunities created for foreign
entrants. It analyzes the competitive landscape of the industry and
performance of three leading players – Allianz, AXA and Assicurazioni
Generali. The forecast for the industry has also been analyzed taking
into consideration the slowdown in the economy and performance of the Read the rest of this entry »

We focus on long-term trends, not fads

Each trend written with recession in mind, offering practical advice
on surviving tough times

We show how brands around the world are already profiting from the
trends

Independent and opinionated

20 years of experience to guide you through the rough years ahead

Based Read the rest of this entry »

Table 1: Overall rating for 29 selected consumer/patient-oriented
health/medical sites.

Table 2: Detailed aggregate evaluations for sites in seven
medical/health category sub-segments. Red dots indicated “top 25%” of
ratings through to black dots which indicate “bottom 25%” of ratings).

Table 3: US online adult users rating “Portal Plus Community”
sub-category Read the rest of this entry »

1 Contents

2 Introduction 14

3 Definitions of the Markets Covered in the Report 15

4 Healthcare Sector Review 18

5 Regulation System 25

6 Pricing and Reimbursement 30

7 Distribution Structure 31

8 Hospital Supplies In Canada 32

9 Disposable Hospital Supplies Read the rest of this entry »

Dublin – Research and Markets (http://www.researchandmarkets.com/research/9da1a9/the_medical_device) has announced the addition of the “The Medical Device Market: Slovakia” report to their offering.
Slovakia represents one of the smaller Central and Eastern European medical device markets, but is the fifth largest in per capita terms. While Slovakia remains less wealthy than its former partner, the Czech Republic, it is now very much a Western-facing Read the rest of this entry »

Accurex Biomedical, Pvt., Ltd.

Adeza Biomedical Corporation (Hologic)

Agilent Technologies, Inc.

Ambri, Ltd.

American Bio Medica Corp.

Ani Biotech

Applied Spectral Imaging

Avitar, Inc.

Axis-Shield

Bayer Corporation

Read the rest of this entry »

Saturday – Sunday – Monday, January 24, 25, 26, 2009
Becky Fowler, Jubilee Foods store manager, points to a package of snack crackers which have not been recalled due to concern about certain peanut butter products. Assistant Store Manager David Frost, left, and Taney County Health Department inspectors Robert Reynolds and Laura Hunter, listen and look at the store’s shelves.
The national peanut butter recall that began weeks ago targeting the Read the rest of this entry »